The Persistent Symptoms and Decreased Quality of Life of COVID-19 Patients (A 3-month Follow-up after Discharge)

Nur Farhanah; Charles Budiman; Muchlis Achsan Udji Sofro; Budi Riyanto; Suharyo Hadisaputro; Muhammad Hussein Gasem

doi:10.3889/oamjms.2022.9755

Authors

Nur Farhanah Department of Internal Medicine, Diponegoro University, Dr. Kariadi Hospital, Semarang, Indonesia; Department of Internal Medicine, Division of Tropical and Infectious Diseases, Diponegoro University, Dr. Kariadi Hospital, Semarang, Indonesia https://orcid.org/0000-0002-7385-3325
Charles Budiman Department of Internal Medicine https://orcid.org/0000-0003-0771-6936
Muchlis Achsan Udji Sofro Department of Internal Medicine, Diponegoro University, Dr. Kariadi Hospital, Semarang, Indonesia; Department of Internal Medicine, Division of Tropical and Infectious Diseases, Diponegoro University, Dr. Kariadi Hospital, Semarang, Indonesia
Budi Riyanto Department of Internal Medicine, Diponegoro University, Dr. Kariadi Hospital, Semarang, Indonesia; Department of Internal Medicine, Division of Tropical and Infectious Diseases, Diponegoro University, Dr. Kariadi Hospital, Semarang, Indonesia
Suharyo Hadisaputro Department of Internal Medicine, Diponegoro University, Dr. Kariadi Hospital, Semarang, Indonesia; Department of Internal Medicine, Division of Tropical and Infectious Diseases, Diponegoro University, Dr. Kariadi Hospital, Semarang, Indonesia
Muhammad Hussein Gasem Department of Internal Medicine, Diponegoro University, Dr. Kariadi Hospital, Semarang, Indonesia; Department of Internal Medicine, Division of Tropical and Infectious Diseases, Diponegoro University, Dr. Kariadi Hospital, Semarang, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2022.9755

Keywords:

Persistent symptoms, EQ-5D-5L, Quality of life, COVID-19 patients, Indonesia

Abstract

Most coronavirus disease 2019 (COVID-19) patients are still experiencing persistent clinical symptoms even after being discharged from the hospital. Previous studies have reported the remaining symptoms in 29%–93% of patients. This condition can have a major impact on a patient’s ability to perform daily activities and have a deleterious effect on their quality of life (QoL).

Objectives: This study aimed to evaluate persistent symptoms and QoL of COVID-19 patients 3 months after discharge from Dr. Kariadi Hospital Semarang, Central Java, Indonesia.

Methods: Confirmed COVID-19 patients were enrolled in this prospective cohort study after discharge from Dr. Kariadi Hospital Semarang from March 1 to May 15, 2021. Telephone interviews were conducted each week in the first month, and every 2 weeks in the second and third months regarding persistent symptoms. EQ-5D-5L questionnaires were completed and evaluated every month for 3 months after hospital discharge.

Results: Of the 104 patients enrolled, 55% were male, with a mean age of 48.96 years. The incidence of persistent symptoms in the first, second, and third months was 49%, 31.7%, and 25%, respectively. The most common persistent symptoms were fatigue, cough, shortness of breath, and nausea. The characteristics of the patients included being overweight/obese, having one or more comorbidities, having five or more symptoms classified as moderate COVID-19, and requiring supplemental oxygen during hospitalization. Based on the EQ-5D questionnaire, most patients reported worsening in the quality of their ability to perform usual activities, feelings of pain/discomfort, and anxiety/depression. The total values of the EQ-5D and EQ-VAS indices were lower than those of the Indonesian general population, indicating a decrease in QoL.

Conclusions: The patients developed persistent symptoms and decreased quality of life during the 3-month following hospital discharge.

Keywords: persistent symptoms, EQ-5D-5L, QoL

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

WHO. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19; 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-openingremarks-at-the-media-briefing-on-covid-19---11-march-2020. [Last accessed on 2020 Mar 11].

Centers for Disease Control and Prevention (CDC). CDC COVID-19 Global Response; 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/globalresponse.html. [Last accessed on 2020 Oct 22]

Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5–6 months after COVID-19 in non-hospitalised subjects: A population-based cohort study. Thorax. 2021;76(4):405-7. https://doi.org/10.1136/thoraxjnl-2020-216377 PMid:33273028 DOI: https://doi.org/10.1136/thoraxjnl-2020-216377

World Health Organization. A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. Geneva, Switzerland: World Health Organization; 2021. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. [Last accessed on 2021 Oct 06].

Dryden M, Mudara C, Vika C, Blumberg L, Mayet N, Cohen C. Long COVID in South Africa: Findings from a Longitudinal Cohort of Patients at One Month After Hospitalisation with SARS-CoV-2, Using an ISARIC Multi-Country Protocol; 2021. Available from: https://www.nicd.ac.za. [Last accessed on 2021 Aug 21]

Mahmud R, Rahman MM, Rassel MA, Monayem FB, Sayeed SK, Islam MS, et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLoS One. 2021;16(4):e0249644. https://doi.org/10.1371/journal.pone.0249644 PMid:33831043 DOI: https://doi.org/10.1371/journal.pone.0249644

Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation. J Med Virol. 2021;93(2):1013-22. https://doi.org/10.1002/jmv.26368 PMid:32729939 DOI: https://doi.org/10.1002/jmv.26368

Arab-Zozani M, Hashemi F, Safari H, Yousefi M, Ameri H. Health-related quality of life and its associated factors in COVID-19 patients. Osong Public Health Res Perspect. 2020;11(5):296-302. https://doi.org/10.24171/j.phrp.2020.11.5.05 PMid:33117634 DOI: https://doi.org/10.24171/j.phrp.2020.11.5.05

Qu G, Zhen Q, Wang W, Fan S, Wu Q, Zhang C, et al. Health‐related quality of life of COVID‐19 patients after discharge: A multicenter follow‐up study. J Clin Nurs. 2021;30(11-12):1742-50. https://doi.org/10.1111/jocn.15733 PMid:33656210 DOI: https://doi.org/10.1111/jocn.15733

Purba FD, Hunfeld JA, Iskandarsyah A, Fitriana TS, Sadarjoen SS, Ramos-Goñi JM, et al. The Indonesian EQ-5D-5L value set. Pharmacoeconomics. 2017;35(11):1153-65. https://doi.org/10.1007/s40273-017-0538-9 PMid:28695543 DOI: https://doi.org/10.1007/s40273-017-0538-9

Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, Nyirenda T, Friedman T, Gupta A, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;15(12):e0243882. https://doi.org/10.1371/journal.pone.0243882 PMid:33306721 DOI: https://doi.org/10.1371/journal.pone.0243882

Chopra V, Flanders SA, O’Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021;174(4):576-8. https://doi.org/10.7326/M20-5661 PMid:33175566 DOI: https://doi.org/10.7326/M20-5661

Rosales-Castillo A, de Los Ríos CG, García JD. Persistent symptoms after acute COVID-19 infection: Importance of follow-up. Med Clin (English Ed). 2021;156(1):35-6. https://doi.org/10.1016/j.medcle.2020.08.003 PMid:33521308 DOI: https://doi.org/10.1016/j.medcle.2020.08.003

Spinicci M, Vellere I, Graziani L, Tilli M, Borchi B, Mencarini J, et al. Clinical and laboratory follow-up after hospitalization for COVID-19 at an Italian tertiary care center. In: Open Forum Infectious Diseases. USA: Oxford University Press; 2021. p. ofab049. DOI: https://doi.org/10.1093/ofid/ofab049

Evlice O, Kuş F, Bektas M. Persistent symptoms after discharge of COVID-19 patients. Infect Dis Clin Microbiol. 2021;3(1):22-9. DOI: https://doi.org/10.36519/idcm.2021.40

Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27(1):89-95. https://doi.org/10.1016/j.cmi.2020.09.023 PMid:32979574 DOI: https://doi.org/10.1016/j.cmi.2020.09.023

Isdijoso W, Kusumastuti RS, Indriani K, Larasati D, Sondakh FA, Siyaranamual M. Project Directors Bambang Widianto, Executive Secretary (Ad-Interim) of TNP2K The National Team for the Acceleration of Poverty Reduction (TNP2K) The SMERU Research Institute The Situation of the Elderly in Indonesia and Access to Social Protection Progra. Jakarta; 2020. Available from: https://www.tnp2k.go.id. [Last accessed 2021 Aug 23]

Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. https://doi.org/10.1016/j.eclinm.2021.101019 PMid:34308300 DOI: https://doi.org/10.1016/j.eclinm.2021.101019

Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. https://doi.org/10.1038/s41598-021-95565-8 PMid:34373540 DOI: https://doi.org/10.1038/s41598-021-95565-8

Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11):e0240784. https://doi.org/10.1371/journal.pone.0240784 PMid:33166287 DOI: https://doi.org/10.1371/journal.pone.0240784

Mendelson M, Nel J, Blumberg L, Madhi SA, Dryden M, Stevens W, et al. Long-COVID: An evolving problem with an extensive impact. S Afr Med J. 2021;111(1):10-2. https://doi.org/10.7196/SAMJ.2020.v111i11.15433 PMid:33403997 DOI: https://doi.org/10.7196/SAMJ.2020.v111i11.15433

Nandasena HM, Pathirathna ML, Atapattu AM, Prasanga PT. Quality of life of COVID 19 patients after discharge: Systematic review. PLoS One. 2022;17(2):e0263941. https://doi.org/10.1371/journal.pone.0263941 PMid:35171956 DOI: https://doi.org/10.1371/journal.pone.0263941

Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737-54. https://doi.org/10.1080/2374423 5.2021.1924397 PMid:34024217 DOI: https://doi.org/10.1080/23744235.2021.1924397

Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: A systematic review. JAMA Netw Open. 2021;4(5):e2111417.https://doi.org/10.1001/jamanetworkopen.2021.11417 PMid:34037731 DOI: https://doi.org/10.1001/jamanetworkopen.2021.11417

Cirulli ET, Barrett KM, Riffle S, Bolze A, Neveux I, Dabe S, et al. Long-term COVID-19 symptoms in a large unselected population. medrxiv. 2020 ;https://doi.org/10.1101/2020.10.07.2 0208702 DOI: https://doi.org/10.1101/2020.10.07.20208702

Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626-31. https://doi.org/10.1038/s41591-021-01292-y PMid:33692530 DOI: https://doi.org/10.1038/s41591-021-01292-y

Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, et al. Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health Eur. 2021;8:100186. https://doi.org/10.1016/j.lanepe.2021.100186 PMid:34386785 DOI: https://doi.org/10.1016/j.lanepe.2021.100186

Iqbal A, Iqbal K, Ali SA, Azim D, Farid E, Baig MD, et al. The COVID-19 sequelae: A cross-sectional evaluation of post-recovery symptoms and the need for rehabilitation of COVID-19 survivors. Cureus. 2021;13(2):e13080. https://doi.org/10.7759/cureus.13080 PMid:33680620 DOI: https://doi.org/10.7759/cureus.13080

Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4-6. https://doi.org/10.1016/j.jinf.2020.08.029 PMid:32853602 DOI: https://doi.org/10.1016/j.jinf.2020.08.029

Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: what is long- COVID and how should we manage it? Lung. 2021;199(2):113-9. https://doi.org/10.1007/s00408-021-00423-z PMid:33569660 DOI: https://doi.org/10.1007/s00408-021-00423-z

Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603-5. https://doi.org/10.1001/jama.2020.12603 PMid:32644129 DOI: https://doi.org/10.1001/jama.2020.12603

Iqlima DE, Wiedyaningsih C, Haris RN. Measurement of health related quality of lifein general population in Indonesia using EQ-5D-5L with online survey. Int J Pharma Sci Res. 2019;10:175-81.